Federica Galimberti

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Comparative safety of lipid-lowering drugs alone or in combination: insights from a systematic review and network meta-analysis.

Comparative safety of lipid-lowering drugs alone or in combination: insights from a systematic review and network meta-analysis.

Journal: Nutrition, metabolism, and cardiovascular diseases : NMCD

Published: March 24, 2026

Efficacy and Safety of Oral PCSK9 Inhibitors: Insights from a Meta-analysis of RCTS.

Efficacy and Safety of Oral PCSK9 Inhibitors: Insights from a Meta-analysis of RCTS.

Journal: European journal of preventive cardiology

Published: March 19, 2026

Lipid clinics worldwide: harmonization and guidance on how to optimally organize and fund. European Atherosclerosis Society consensus statement across 55 countries and more than 500 lipid clinics.

Lipid clinics worldwide: harmonization and guidance on how to optimally organize and fund. European Atherosclerosis Society consensus statement across 55 countries and more than 500 lipid clinics.

Journal: Atherosclerosis

Published: March 18, 2026

Real-world management of familial hypercholesterolemia in paediatric patients: a 3-year follow-up from the LIPIGEN registry.

Real-world management of familial hypercholesterolemia in paediatric patients: a 3-year follow-up from the LIPIGEN registry.

Journal: Atherosclerosis

Published: December 13, 2025

Colchicine and cardiovascular events: An updated meta-analysis of published randomized controlled trials.

Colchicine and cardiovascular events: An updated meta-analysis of published randomized controlled trials.

Journal: Journal of internal medicine

Published: November 14, 2025

Contemporary Management of Familial and Multifactorial Chylomicronemia Syndromes in Italy: Insights From the National LIPIGEN Registry.

Contemporary Management of Familial and Multifactorial Chylomicronemia Syndromes in Italy: Insights From the National LIPIGEN Registry.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: October 16, 2025

Reply to: "Does statin matter when it comes to Lipoprotein(a) levels?"

Reply to: "Does statin matter when it comes to Lipoprotein(a) levels?"

Journal: Atherosclerosis

Published: July 21, 2025

ApoC-III as Therapeutic Target: Is it Primetime for Clinical Use?

ApoC-III as Therapeutic Target: Is it Primetime for Clinical Use?

Journal: Current atherosclerosis reports

Published: June 28, 2025

Effect of lipid-lowering therapies on lipoprotein(a) levels: a comprehensive meta-analysis of randomized controlled trials.

Effect of lipid-lowering therapies on lipoprotein(a) levels: a comprehensive meta-analysis of randomized controlled trials.

Journal: Atherosclerosis

Published: March 19, 2025

Predictors and benefits of lipid-lowering therapy initiation after an atherosclerotic cardiovascular event: a retrospective cohort study.

Predictors and benefits of lipid-lowering therapy initiation after an atherosclerotic cardiovascular event: a retrospective cohort study.

Journal: Frontiers in pharmacology

Published: March 05, 2025

Contribution and interaction of polygenic predisposition and family history of coronary heart disease in predicting cardiovascular risk.

Contribution and interaction of polygenic predisposition and family history of coronary heart disease in predicting cardiovascular risk.

Journal: Atherosclerosis

Published: February 12, 2025

Attitudes and confidence toward deprescribing: a survey among Italian general practitioners.

Attitudes and confidence toward deprescribing: a survey among Italian general practitioners.

Journal: BMC primary care

Published: February 03, 2025

Showing 1-12 of 36

Last Updated: 09/26/2026